Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
Apply
ADT, Leuprolide, Darolutamide, Pembrolizumab
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step